• Factors ID’d for Strong Antibody Response in COVID-19

    Healthday News COVID-19, Critical Care, Emergency Medicine, Family Practice, HealthDay News, Internal Medicine, Latest News, OBGYN & Women's Health October 26, 2020
  • COVID-19 Pandemic Challenges Osteoporosis Management

    Healthday News COVID-19, Family Practice, Geriatrics, HealthDay News, Internal Medicine, Latest News, OBGYN & Women's Health October 26, 2020
  • AstraZeneca, J&J Resume U.S. COVID-19 Vaccine Trials

    Healthday News COVID-19, Critical Care, Emergency Medicine, Family Practice, HealthDay News, Internal Medicine, Latest News, OBGYN & Women's Health, Pharmacy October 26, 2020
  • Survival From COVID-19 High in Patients With Psoriasis

    Healthday News COVID-19, Critical Care, Emergency Medicine, Family Practice, HealthDay News, Internal Medicine, Latest News, Pharmacy October 23, 2020
  • FDA Needs More Safety Data on COVID-19 Vaccines, Experts Say

    Healthday News COVID-19, Critical Care, Emergency Medicine, Family Practice, HealthDay News, Internal Medicine, Latest News, OBGYN & Women's Health, Pharmacy October 23, 2020

Sponsored by Janssen Pharmaceuticals, Inc. Intended for Healthcare Professionals

cushing-and-endogenous-hypercortisolism.com
Navigation
  • COVID-19
  • Latest News
  • Travel Vaccine News
  • Influenza Vaccine News
  • Search
  • COVID-19
  • Latest News
  • Travel Vaccine News
  • Influenza Vaccine News
  • Search
Home 2021 November 16

Post Archive by Day

View Post

American College of Allergy, Asthma & Immunology, Nov. 4-8

In COVID-19, Latest News
by Healthday
November 16, 2021

The 2021 Annual Scientific Meeting of the American College of Allergy, Asthma & Immunology

View Post

Two Doses of 10 μg BNT162b2 Safe, Efficacious in 5- to 11-Year-Olds

In COVID-19, Latest News
by Healthday
November 16, 2021

BNT162b2 vaccine had favorable safety profile in 5- to 11-year-olds similar to that seen in other age groups

View Post

Pfizer Asks FDA for Emergency Approval of Its COVID-19 Antiviral Pill

In COVID-19, Latest News
by Healthday
November 16, 2021

Request comes shortly after clinical trial testing the drug was halted early due to overwhelming evidence of its effectiveness

View Post

Pfizer COVID-19 Pill to Be Made, Sold Cheaply in 95 Poor Countries

In COVID-19, Latest News
by Healthday
November 16, 2021

Countries included in licensing deal mostly in Africa and Asia and account for more than half of the world’s population

TRENDING

  • Malaria Monoclonal Antibody Provides Some Protection
  • New World Screwworm Confirmed in Nuevo Leon
  • UK Vaccination Campaign Protects Newborns this Winter
  • Should Canada and Mexico Visitors Verify Measles Immunity
  • New Vaccine Panel Recommends Doctor Consults Before COVID Shots

By Publish Date

November 2021
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
« Oct   Dec »

LATEST ARTICLES

  • Malaria Monoclonal Antibody Provides Some Protection September 25, 2025
  • New World Screwworm Confirmed in Nuevo Leon September 22, 2025
  • UK Vaccination Campaign Protects Newborns this Winter September 22, 2025

Sponsored by Janssen Pharmaceuticals, Inc. Intended for U.S. Healthcare Professionals.

Powered by eHealthcare Solutions. | Privacy Policy

  • COVID-19
  • Travel Vaccine News
  • Family Practice
  • OBGYN & Women’s Health
  • Clinical Guidelines
eHealthcare Solutions (EHS) manages advertising on this website. We use cookies to ensure that we give you the best experience on our website. By continuing, you agree to the use of cookies as per the EHS Privacy Policy